Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Counter

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|April 25, 2003
Telomere shortening in cultured autografts of patients with burnsChristopher M Counter, William Press, Carolyn C Compton
Current Biology : CB|December 29, 2004
Loss of hPot1 function leads to telomere instability and a cut-like phenotypeTimothy Veldman, Katherine T Etheridge, Christopher M Counter
Genes & Development|July 20, 2007
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesisBrooke Ancrile, Kian-Huat Lim, Christopher M Counter
Molecular Cancer Research : MCR|February 11, 2010
Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesisSameer H Issaq, Kian-Huat Lim, Christopher M Counter
Carcinogenesis|October 7, 2009
ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesisKevin M O'Hayer, Donita C Brady, Christopher M Counter
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Genetically engineered human cancer models utilizing mammalian transgene expressionS DiSean Kendall, Stacey J Adam, Christopher M Counter
Molecular and Cellular Biology|August 5, 2009
POT1 association with TRF2 regulates telomere lengthMegan F Kendellen, Katharine S Barrientos, Christopher M Counter
Molecular Interventions|March 12, 2008
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeuticsBrooke B Ancrile, Kevin M O'Hayer, Christopher M Counter
Nature Communications|March 6, 2025
The essential clathrin adapter protein complex-2 is tumor suppressive specifically in vivoSeth P Zimmerman, Lili B DeGraw, Christopher M Counter
Plos One|March 28, 2024
p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesisÖzgün Le Roux, Jeffery I Everitt, Christopher M Counter
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|April 25, 2003
Telomere shortening in cultured autografts of patients with burnsChristopher M Counter, William Press, Carolyn C Compton
Current Biology : CB|December 29, 2004
Loss of hPot1 function leads to telomere instability and a cut-like phenotypeTimothy Veldman, Katherine T Etheridge, Christopher M Counter
Genes & Development|July 20, 2007
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesisBrooke Ancrile, Kian-Huat Lim, Christopher M Counter
Molecular Cancer Research : MCR|February 11, 2010
Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesisSameer H Issaq, Kian-Huat Lim, Christopher M Counter
Carcinogenesis|October 7, 2009
ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesisKevin M O'Hayer, Donita C Brady, Christopher M Counter
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Genetically engineered human cancer models utilizing mammalian transgene expressionS DiSean Kendall, Stacey J Adam, Christopher M Counter
Molecular and Cellular Biology|August 5, 2009
POT1 association with TRF2 regulates telomere lengthMegan F Kendellen, Katharine S Barrientos, Christopher M Counter
Molecular Interventions|March 12, 2008
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeuticsBrooke B Ancrile, Kevin M O'Hayer, Christopher M Counter
Nature Communications|March 6, 2025
The essential clathrin adapter protein complex-2 is tumor suppressive specifically in vivoSeth P Zimmerman, Lili B DeGraw, Christopher M Counter
Plos One|March 28, 2024
p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesisÖzgün Le Roux, Jeffery I Everitt, Christopher M Counter
Pageof 9